Policy Briefs on THE
ECONOMIC IMPACT OF HIV
Brief 1: The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality
By Markus Haacker, Kate Harris, Gesine Meyer-Rath
August 2021
Key Points
- HIV transmission and AIDS-related mortality have been declining steeply and steadily around the world. However, because of the interplay of longer survival and lower HIV transmission, the number of people living with HIV continues to increase, and progress lags behind the targets set out in the UNAIDS strategy towards “ending AIDS” by 2030 (even before the disruptions caused by Covid-19 are factored in).
- Progress in reducing HIV transmission and AIDS-related mortality has tended to be faster in countries with high HIV prevalence, and has been fairly even across countries with different levels of economic development.
- Large discrepancies in HIV programme achievements persist across countries. If all countries had caught up with or come close to the countries with the most successful HIV programmes to date, then over one-third of AIDS-related deaths and adult HIV infections, and about 60 percent of infections through mother-to-child transmission of HIV, could have been averted in 2019.
Summary Briefs
The summary briefs provide an overview of three main areas of economic impact.
Master Slide Set
Policy Briefs
The policy briefs provide more detail on the evidence available on each of the topics.
1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality
2. Increased Health and Life Prospects and Their Economic Valuation
3. HIV, Population Dynamics and the Labour Force
4. Human Capital
5. Capital and Investment
6. Productivity and Employment of People Living with HIV
7. Economic Growth – Overview
8. Interactions Between HIV and Poverty
9. Disease Burden Across Population Sub-Groups
10. Trade-offs between Allocation to Health and Other Sectors
11. Domestic Public Funding for HIV
12. Trade-offs and Synergies between HIV and Other Health Objectives
13. Assessing Cost Effectiveness Across HIV and Health Interventions
14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding
15. Public and Private Provision of Health and HIV Services
16. Trade-offs within the HIV Budget
17. The Economics of HIV and of HIV Programmes in the Era of Covid-19
Brief 1: The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality
By Markus Haacker, Kate Harris, Gesine Meyer-Rath
August 2021
Key Points
- HIV transmission and AIDS-related mortality have been declining steeply and steadily around the world. However, because of the interplay of longer survival and lower HIV transmission, the number of people living with HIV continues to increase, and progress lags behind the targets set out in the UNAIDS strategy towards “ending AIDS” by 2030 (even before the disruptions caused by Covid-19 are factored in).
- Progress in reducing HIV transmission and AIDS-related mortality has tended to be faster in countries with high HIV prevalence, and has been fairly even across countries with different levels of economic development.
- Large discrepancies in HIV programme achievements persist across countries. If all countries had caught up with or come close to the countries with the most successful HIV programmes to date, then over one-third of AIDS-related deaths and adult HIV infections, and about 60 percent of infections through mother-to-child transmission of HIV, could have been averted in 2019.
Technical Briefs
The technical briefs provide more detail on the evidence available on each of the topics.
1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality
2. Increased Health and Life Prospects and Their Economic Valuation
3. HIV, Population Dynamics and the Labour Force
4. Human Capital
5. Capital and Investment
6. Productivity and Employment of People Living with HIV
7. Economic Growth – Overview
8. Interactions Between HIV and Poverty
9. Disease Burden Across Population Sub-Groups
10. Trade-offs between Allocation to Health and Other Sectors
11. Domestic Public Funding for HIV
12. Trade-offs and Synergies between HIV and Other Health Objectives
13. Assessing Cost Effectiveness Across HIV and Health Interventions
14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding
15. Public and Private Provision of Health and HIV Services
16. Trade-offs within the HIV Budget
17. The Economics of HIV and of HIV Programmes in the Era of Covid-19
Wits Health Consortium, University of the Witwatersrand